Pieter Rottiers

Directeur Général chez Intrexon ActoBiotics NV

Consumer Services

Health Technology

Postes actifs de Pieter Rottiers

Sociétés	Poste	Début	Fin
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Directeur/Membre du Conseil	-	-
	Directeur Général	-	-
	Directeur Technique/Scientifique/R&D	09/10/2013	-
	Corporate Officer/Principal	21/08/2009	09/10/2013

Sociétés	Poste	Début	Fin
Vlaams Instituut voor Biotechnologie - Flanders Institute Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.	Corporate Officer/Principal	01/01/2006	01/01/2006

Ghent University

Doctorate Degree

Internationale

Belgique

Opérationnelle

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Sectorielle

Consumer Services	3
Health Technology	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Intrexon ActoBiotics NV Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.	Health Technology

Entreprise privées

Health Technology